FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

717178009: Reslizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3308594018 Reslizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3308595017 Reslizumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Reslizumab Is a Respiratory system agent true Inferred relationship Existential restriction modifier
Reslizumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Reslizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Reslizumab Is a Substance with interleukin 5 receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Reslizumab Has disposition Interleukin 5 receptor antagonist true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only reslizumab in parenteral dose form (medicinal product form) Has active ingredient True Reslizumab Inferred relationship Existential restriction modifier 1
Product containing reslizumab (medicinal product) Has active ingredient True Reslizumab Inferred relationship Existential restriction modifier 1
Reslizumab Has active ingredient True Reslizumab Inferred relationship Existential restriction modifier 1
Product containing reslizumab in parenteral dose form (medicinal product form) Has active ingredient True Reslizumab Inferred relationship Existential restriction modifier 1
Reslizumab 100mg/10ml solution for infusion vials Has specific active ingredient True Reslizumab Inferred relationship Existential restriction modifier
Cinqaero 100mg/10ml concentrate for solution for infusion vials (Teva UK Ltd) Has specific active ingredient True Reslizumab Inferred relationship Existential restriction modifier
Reslizumab 100mg/10ml solution for infusion vials 1 vial Has specific active ingredient True Reslizumab Inferred relationship Existential restriction modifier
Cinqaero 100mg/10ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has specific active ingredient True Reslizumab Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials Has specific active ingredient True Reslizumab Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Has specific active ingredient True Reslizumab Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials 1 vial Has specific active ingredient True Reslizumab Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has specific active ingredient True Reslizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start